Compare Pro-Dex, Inc. with Similar Stocks
Dashboard
1
High Management Efficiency with a high ROCE of 19.57%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 1.01 times
3
Poor long term growth as Operating profit has grown by an annual rate 8.65% of over the last 5 years
4
The company has declared Positive results for the last 5 consecutive quarters
5
With ROE of 25.14%, it has a very attractive valuation with a 3.97 Price to Book Value
6
High Institutional Holdings at 29.81%
7
Underperformed the market in the last 1 year
Stock DNA
Pharmaceuticals & Biotechnology
USD 133 Million (Micro Cap)
16.00
NA
0.00%
0.08
19.05%
3.21
Revenue and Profits:
Net Sales:
17 Million
(Quarterly Results - Jun 2025)
Net Profit:
1 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
13.96%
0%
13.96%
6 Months
-15.87%
0%
-15.87%
1 Year
11.97%
0%
11.97%
2 Years
79.34%
0%
79.34%
3 Years
130.1%
0%
130.1%
4 Years
70.66%
0%
70.66%
5 Years
15.47%
0%
15.47%
Pro-Dex, Inc. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
13.84%
EBIT Growth (5y)
8.65%
EBIT to Interest (avg)
6.83
Debt to EBITDA (avg)
1.01
Net Debt to Equity (avg)
0.25
Sales to Capital Employed (avg)
1.19
Tax Ratio
24.38%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
30.10%
ROCE (avg)
19.57%
ROE (avg)
20.28%
Valuation key factors
Factor
Value
P/E Ratio
16
Industry P/E
Price to Book Value
3.97
EV to EBIT
12.72
EV to EBITDA
11.51
EV to Capital Employed
3.37
EV to Sales
2.32
PEG Ratio
0.18
Dividend Yield
NA
ROCE (Latest)
26.48%
ROE (Latest)
25.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Bearish
Moving Averages
Bearish (Daily)
KST
Bullish
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
Mildly Bearish
Mildly Bearish
Shareholding Snapshot : Sep 2025
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 10 Schemes (11.16%)
Foreign Institutions
Held by 18 Foreign Institutions (1.33%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
Jun'25
Mar'25
Change(%)
Net Sales
17.50
17.40
0.57%
Operating Profit (PBDIT) excl Other Income
1.70
3.90
-56.41%
Interest
0.20
0.20
Exceptional Items
0.50
0.60
-16.67%
Consolidate Net Profit
1.20
3.30
-63.64%
Operating Profit Margin (Excl OI)
76.80%
209.00%
-13.22%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2025 is 0.57% vs 3.57% in Mar 2025
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2025 is -63.64% vs 65.00% in Mar 2025
Annual Results Snapshot (Consolidated) - Jun'24
Jun'24
Jun'23
Change(%)
Net Sales
53.80
46.10
16.70%
Operating Profit (PBDIT) excl Other Income
8.30
6.60
25.76%
Interest
0.60
0.50
20.00%
Exceptional Items
-4.10
3.90
-205.13%
Consolidate Net Profit
2.10
7.10
-70.42%
Operating Profit Margin (Excl OI)
133.20%
125.00%
0.82%
USD in Million.
Net Sales
YoY Growth in year ended Jun 2024 is 16.70% vs 9.76% in Jun 2023
Consolidated Net Profit
YoY Growth in year ended Jun 2024 is -70.42% vs 54.35% in Jun 2023
About Pro-Dex, Inc. 
Pro-Dex, Inc.
Pharmaceuticals & Biotechnology
Pro-Dex, Inc. (Pro-Dex) designs and produces surgical and dental instruments and motion control products used in the medical, factory automation and scientific research industries. The Company operates through three segments: Pro-Dex, OMS and Engineering Services Division (ESD). The Pro-Dex segment provides primarily medical and dental instruments using shared production and assembly machines and workforce. The OMS segment is engaged in providing multi-axis motion control applications. In addition to Pro-Dex, the names Micro Motors and Oregon Micro Systems are used for marketing purposes as brand names. The Company provides engineering consulting services, as well as quality and regulatory consulting services, to a range of industries through EDS.
Company Coordinates 
Company Details
2361 McGaw Ave , IRVINE CA : 92614
Registrar Details






